Search research articles
Contact Us
Filters
Showing results (231-240 of 233) with videos related to
Page
of 24
Sort By:
You have reached the last page of results.
This site can display upto 233 results.
The Lancet. Gastroenterology & Hepatology
|
January 12, 2023
Genomic diagnosis and care co-ordination for monogenic inflammatory bowel disease in children and adults: consensus guideline on behalf of the British Society of Gastroenterology and British Society of Paediatric Gastroenterology, Hepatology and Nutrition
Jochen Kammermeier, Christopher A Lamb, Kelsey D J Jones, et al.
BMC Medicine
|
April 24, 2015
Ready-to-use therapeutic food with elevated n-3 polyunsaturated fatty acid content, with or without fish oil, to treat severe acute malnutrition: a randomized controlled trial
Kelsey D J Jones, Rehema Ali, Maureen A Khasira, et al.
Alimentary Pharmacology & Therapeutics
|
August 30, 2022
Implications for sequencing of biologic therapy and choice of second anti-TNF in patients with inflammatory bowel disease: results from the IMmunogenicity to Second Anti-TNF therapy (IMSAT) therapeutic drug monitoring study
Neil Chanchlani, Simeng Lin, Marcus K Auth, et al.
Page
of 24
Search research articles
Search
Showing results (231-240 of 233) with videos related to
Sort By:
Page
of 24
You have reached the last page of results.
This site can display upto 233 results.
The Lancet. Gastroenterology & Hepatology
|
January 12, 2023
Genomic diagnosis and care co-ordination for monogenic inflammatory bowel disease in children and adults: consensus guideline on behalf of the British Society of Gastroenterology and British Society of Paediatric Gastroenterology, Hepatology and Nutrition
Jochen Kammermeier, Christopher A Lamb, Kelsey D J Jones, et al.
BMC Medicine
|
April 24, 2015
Ready-to-use therapeutic food with elevated n-3 polyunsaturated fatty acid content, with or without fish oil, to treat severe acute malnutrition: a randomized controlled trial
Kelsey D J Jones, Rehema Ali, Maureen A Khasira, et al.
Alimentary Pharmacology & Therapeutics
|
August 30, 2022
Implications for sequencing of biologic therapy and choice of second anti-TNF in patients with inflammatory bowel disease: results from the IMmunogenicity to Second Anti-TNF therapy (IMSAT) therapeutic drug monitoring study
Neil Chanchlani, Simeng Lin, Marcus K Auth, et al.
Page
of 24